1. Home
  2. TECX vs SHBI Comparison

TECX vs SHBI Comparison

Compare TECX & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • SHBI
  • Stock Information
  • Founded
  • TECX 2019
  • SHBI 1876
  • Country
  • TECX United States
  • SHBI United States
  • Employees
  • TECX N/A
  • SHBI N/A
  • Industry
  • TECX
  • SHBI Major Banks
  • Sector
  • TECX
  • SHBI Finance
  • Exchange
  • TECX Nasdaq
  • SHBI Nasdaq
  • Market Cap
  • TECX 387.1M
  • SHBI 569.1M
  • IPO Year
  • TECX 2018
  • SHBI N/A
  • Fundamental
  • Price
  • TECX $15.06
  • SHBI $17.04
  • Analyst Decision
  • TECX Buy
  • SHBI Buy
  • Analyst Count
  • TECX 6
  • SHBI 1
  • Target Price
  • TECX $79.17
  • SHBI $20.00
  • AVG Volume (30 Days)
  • TECX 502.6K
  • SHBI 116.5K
  • Earning Date
  • TECX 11-06-2025
  • SHBI 10-23-2025
  • Dividend Yield
  • TECX N/A
  • SHBI 2.82%
  • EPS Growth
  • TECX N/A
  • SHBI 169.45
  • EPS
  • TECX N/A
  • SHBI 1.61
  • Revenue
  • TECX N/A
  • SHBI $208,209,000.00
  • Revenue This Year
  • TECX N/A
  • SHBI N/A
  • Revenue Next Year
  • TECX N/A
  • SHBI $16.05
  • P/E Ratio
  • TECX N/A
  • SHBI $10.57
  • Revenue Growth
  • TECX N/A
  • SHBI 24.24
  • 52 Week Low
  • TECX $13.70
  • SHBI $11.47
  • 52 Week High
  • TECX $61.07
  • SHBI $17.61
  • Technical
  • Relative Strength Index (RSI)
  • TECX 31.98
  • SHBI 57.56
  • Support Level
  • TECX $15.92
  • SHBI $16.77
  • Resistance Level
  • TECX $18.61
  • SHBI $17.22
  • Average True Range (ATR)
  • TECX 1.60
  • SHBI 0.32
  • MACD
  • TECX -0.46
  • SHBI -0.03
  • Stochastic Oscillator
  • TECX 0.49
  • SHBI 42.11

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About SHBI Shore Bancshares Inc

Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.

Share on Social Networks: